NATCO Pharma Statistics

Total Valuation

NATCO Pharma has a market cap or net worth of INR 170.71 billion. The enterprise value is 141.32 billion.

Market Cap	170.71B
Enterprise Value	141.32B

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	Feb 18, 2026

Share Statistics

NATCO Pharma has 179.11 million shares outstanding. The number of shares has decreased by -0.00% in one year.

Current Share Class	179.11M
Shares Outstanding	179.11M
Shares Change (YoY)	-0.00%
Shares Change (QoQ)	-0.03%
Owned by Insiders (%)	29.59%
Owned by Institutions (%)	10.48%
Float	83.32M

Valuation Ratios

The trailing PE ratio is 10.96 and the forward PE ratio is 20.19.

PE Ratio	10.96
Forward PE	20.19
PS Ratio	3.74
PB Ratio	1.97
P/TBV Ratio	2.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	9.08
EV / Sales	3.10
EV / EBITDA	7.86
EV / EBIT	8.73
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.03
Debt / EBITDA	0.15
Debt / FCF	n/a
Interest Coverage	55.25

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	23.50%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	5.37%
Revenue Per Employee	10.87M
Profits Per Employee	3.71M
Employee Count	4,199
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NATCO Pharma has paid 3.08 billion in taxes.

Income Tax	3.08B
Effective Tax Rate	16.53%

Stock Price Statistics

The stock price has increased by +23.90% in the last 52 weeks. The beta is 0.19, so NATCO Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.19
52-Week Price Change	+23.90%
50-Day Moving Average	879.02
200-Day Moving Average	882.43
Relative Strength Index (RSI)	63.84
Average Volume (20 Days)	2,740,956

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NATCO Pharma had revenue of INR 45.63 billion and earned 15.57 billion in profits. Earnings per share was 86.94.

Revenue	45.63B
Gross Profit	37.40B
Operating Income	16.08B
Pretax Income	18.64B
Net Income	15.57B
EBITDA	17.84B
EBIT	16.08B
Earnings Per Share (EPS)	86.94

Full Income Statement

Balance Sheet

The company has 32.04 billion in cash and 2.61 billion in debt, giving a net cash position of 29.44 billion or 164.35 per share.

Cash & Cash Equivalents	32.04B
Total Debt	2.61B
Net Cash	29.44B
Net Cash Per Share	164.35
Equity (Book Value)	86.54B
Book Value Per Share	482.88
Working Capital	n/a

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 81.97%, with operating and profit margins of 35.24% and 34.13%.

Gross Margin	81.97%
Operating Margin	35.24%
Pretax Margin	40.84%
Profit Margin	34.13%
EBITDA Margin	39.11%
EBIT Margin	35.24%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.52%.

Dividend Per Share	5.00
Dividend Yield	0.52%
Dividend Growth (YoY)	-16.67%
Years of Dividend Growth	n/a
Payout Ratio	5.75%
Buyback Yield	0.00%
Shareholder Yield	0.53%
Earnings Yield	9.12%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on November 26, 2015. It was a forward split with a ratio of 5.

Last Split Date	Nov 26, 2015
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	1